Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Kirby · SciRah

Researcher profile · Semantic Scholar

L. Kirby

Share profile

L. Kirby — researcher profile on SciRah

h-index: 9
Works: 23
Citations: 1,177

Most-cited papers

Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2).
Peter Oelkers, L. Kirby, J. Heubi, P. Dawson
1997Journal of Clinical Investigation370 citations Open access
Semantic Scholar
Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter.
A. Craddock, M. W. Love, R. W. Daniel, L. Kirby +3 more
1998American Journal of Physiology - Gastrointestinal and Liver Physiology313 citations Open access
Semantic Scholar
Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer
M. Robertson, J. Mier, T. Logan, M. Atkins +12 more
2006Clinical Cancer Research164 citations Open access
Semantic Scholar
A Dose-Escalation Study of Recombinant Human Interleukin-18 Using Two Different Schedules of Administration in Patients with Cancer
M. Robertson, J. Kirkwood, T. Logan, K. Koch +6 more
2008Clinical Cancer Research121 citations Open access
Semantic Scholar
First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer
V. Chung, E. Heath, W. Schelman, Brendan Johnson +5 more
2012Cancer Chemotherapy and Pharmacology84 citations
Semantic Scholar
Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter.
A. Craddock, M. W. Love, R. W. Daniel, L. Kirby +3 more
1998American Journal of Physiology33 citations Open access
Semantic Scholar
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study
M. Maris, G. Salles, W. Kim, Tae Min Kim +16 more
2024Targeted oncology14 citations Open access
Semantic Scholar
Ketoconazole and Rifampin Significantly Affect the Pharmacokinetics, But Not the Safety or QTc Interval, of Casopitant, a Neurokinin‐1 Receptor Antagonist
B. Johnson, L. Adams, Ke Zhang, S. Gainer +6 more
2010Journal of clinical pharmacology13 citations
Semantic Scholar
First-in-human study of the B7-H4 antibody-drug conjugate (ADC) AZD8205 in patients with advanced/metastatic solid tumors.
F. Meric-Bernstam, D. Oh, Y. Naito, Toshio Shimizu +12 more
2022Journal of Clinical Oncology11 citations
Semantic Scholar
Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron
L. Adams, Brendan Johnson, Ke Zhang, Lin Yue +3 more
2009Supportive Care in Cancer9 citations Open access
Semantic Scholar
Phase I study of recombinant human IL-18 (rhIL-18) administered as five daily intravenous infusions every 28 days in patients with solid tumors
M. Robertson, J. Kirkwood, T. Logan, H. Blair +6 more
20058 citations
Semantic Scholar
Tolerability and anti-tumor activity of recombinant human IL-18 (rhIL-18) administered as five daily intravenous infusions in patients with solid tumors.
M. Robertson, J. Mier, T. Logan, H. Koon +6 more
2004Journal of Clinical Oncology7 citations
Semantic Scholar
Effect of hepatic or renal impairment on the pharmacokinetics of casopitant, a NK-1 receptor antagonist
J. Bauman, J. Antal, L. Adams, Brendan Johnson +7 more
2012Investigational new drugs6 citations
Semantic Scholar
Tolerability and anti-tumor activity of recombinant human IL-18 (rhIL-18) administered as five daily intravenous infusions in patients with solid tumors
M. Robertson, J. Mier, T. Logan, H. Koon +6 more
20046 citations
Semantic Scholar
Continuous spectrophotometric assay of conjugated bile acid hydrolase
L. Kirby, R. A. Klein, J. P. Coleman
1995Lipids5 citations
Semantic Scholar
Metabolic fate and hepatocyte toxicity of reverse amide analogs of conjugated ursodeoxycholate in the rat.
James P. Coleman, L. Kirby, K. D. R. Setchell, Phillip B. Hylemon +3 more
1998Journal of Steroid Biochemistry and Molecular Biology4 citations
Semantic Scholar
Synthesis and characterization of novel analogs of conjugated bile acids containing reversed amide bonds.
J. P. Coleman, L. Kirby, R. A. Klein
1995Journal of Lipid Research4 citations
Semantic Scholar
Phase I first-in-human study of the centromere-associated protein E (CENP-E) inhibitor GSK923295 in patients with advanced solid tumors (study CPE107602).
K. Holen, E. Heath, W. Schelman, L. Kirby +5 more
20102 citations
Semantic Scholar
270 POSTER Recombinant human IL-18 (iboctadekin) PKPD and clinical activity in phase I-II
K. Koch, D. Jaworski, L. Kirby, S. Kathman +6 more
20062 citations
Semantic Scholar
RHEA-1: First-in-human (FIH) study of AZD9793, a first-in-class CD8-guided T cell-engager (TCE) for glypican-3-positive (GPC3+) advanced or metastatic hepatocellular carcinoma (HCC).
S. Champiat, P. Grierson, Jason Chia-Hsun Hsieh, M. Ikeda +11 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Phase I dose escalation study to assess tolerability and pharmacokinetics of recombinant human IL-18 (rhIL-18) administered as fourteen daily subcutaneous injections in patients with solid tumors.
N. Lewis, J. Gollob, R. B. Cohen, M. Thoreson +6 more
2004Journal of Clinical Oncology1 citations
Semantic Scholar
Effect of Casopitant, a Novel NK‐1 Receptor Antagonist, on the Pharmacokinetics and Pharmacodynamics of Steady‐State Warfarin
L. Kirby, Brendan Johnson, L. Adams, Derek J. Eberwein +5 more
2010Journal of clinical pharmacology0 citations
Semantic Scholar
Abstract C132: Effect of hepatic or renal impairment on the pharmacokinetics of casopitant
J. Bauman, J. Antal, L. Adams, Brendan Johnson +7 more
20090 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Robertson×6
Invite
M. Robertson — researcher profile on SciRah
T. Logan×6
Invite
T. Logan — researcher profile on SciRah
Brendan Johnson×6
Invite
Brendan Johnson — researcher profile on SciRah
S. Kathman×5
Invite
S. Kathman — researcher profile on SciRah

×5

Invite

J. Weisenbach — researcher profile on SciRah

Invite

M. Dar — researcher profile on SciRah

Invite

J. Mier — researcher profile on SciRah

Invite

C. Oei — researcher profile on SciRah

Invite

L. Thurmond — researcher profile on SciRah

Invite

P. Lebowitz — researcher profile on SciRah

Invite

P. Dawson — researcher profile on SciRah

Invite

H. Koon — researcher profile on SciRah